Elevated Prevalence of Hepatitis B in Mexican Hemodialysis Patients. A Multicentric Survey

Archives of Medical Research

Volumn 41, Issue 4, 2010, Pages 251-254

  Paniagua, Ramón ^a   Villasís Keever, Angelina ^b   Prado Uribe, María del Carmen ^a   Ventura García, María de Jesús ^a   Alcántara Ortega, Guadalupe ^a   Ponce de Leon, Samuel R ^c   Cure Bolt, Nancy ^b   Rangel Frausto, Sigfrido ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b BRISTOL MYERS SQUIBB   (United States)

^c Laboratory of Biologics and Reagents of México   (Mexico)

Author keywords

ESRD; Hemodialysis; Hepatitis B; Hepatitis C; Infection control

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL ARTICLE; FEMALE; HEALTH CENTER; HEALTH SURVEY; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; MALE; MEXICO; MIXED INFECTION; PATIENT SELECTION; POPULATION; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; VIRUS INFECTION; ADOLESCENT; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MIDDLE AGED; MULTICENTER STUDY; RENAL REPLACEMENT THERAPY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMANS; MALE; MEXICO; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; YOUNG ADULT;

EID: 77954653958     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.05.001     Document Type: Article

References (26)

1. World Health Organization Fact Sheet; http://www.who.int.
2. Centers for Disease Control Fact Sheet; http://www.cdc.gov.
3. Valdespino J.L., Conde-González C.J., Olaiz-Fernández G., et al. Prevalence of hepatitis B infection and carrier status among adults in Mexico. Salud Publica Mex 2007, 49(suppl 3):S404-S411.
4. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 2000, 18(suppl 1):S17-S19.
5. Fay O.H. Hepatitis B in Latin America: epidemiological patterns and eradication surgery. Vaccine 1990, 8(suppl1):86-92.
6. Burdick R.A., Bragg-Gresham J.L., Woods J.D., et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2003, 63:2222-2229.
7. Finelli L., Miller J., Tokars J., et al. National Surveillance of Dialysis-Associated Diseases in the United Stated, 2002. Semin Dialysis 2005, 18:52-61.
8. Carl M., Francis D.P., Maynard J.E. A common-source outbreak of hepatitis B in a hemodialysis unit. Dial Transplant 1983, 12:222-229.
9. Alter M.J., Althone J., Maynard J.E. Hepatitis B virus transmission associated with a multiple dose vial in a hemodialysis unit. Ann Intern Med 1983, 99:330-333.
10. Zaidi-Jacobson M., Navarrete-Romero M.E., Romero-Oliveros M.C., et al. Hepatitis B at a hemodialysis unit: description of an outbreak and control measures. Salud Publica Mex 1990, 32:269-275.
11. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep 1988, 37:377-382.
12. Fabrizi F., Bunnapradist S., Martin P. HBV infection in patients with end-stage renal disease. Semin Liver Dis 2004, 24(suppl 2):69-77.
13. Frenk J., Gonzalez-Pier E., Gomez-Dantes O., et al. Comprehensive reform to improve health system performance in Mexico. Lancet 2006, 368:1524-1534.
14. Norma Oficial Mexicana NOM-171-SSA1-1998, Para La Practica de Hemodialisis.
15. Paniagua R., Ramos A., Fabian R., et al. Chronic kidney disease and dialysis in Mexico. Perit Dial Int 2007, 27:405-409.
16. Alter M.J., Favero M.S., Maynard J.E. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis 1986, 153:1149-1151.
17. Assarehzadegan M.A., Shakerinejad G., Noroozkohnejad R., et al. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Saudi J Kidney Dis Transpl 2009, 20:681-684.
18. Al Hijazat M., Ajlouni Y.M. Hepatitis B infection among patients receiving chronic hemodialysis at the Royal Medical Services in Jordan. Saudi J Kidney Dis Transpl 2008, 19:260-267.
19. Cao Y.L., Wang S.X., Zhu Z.M. Hepatitis B viral infection in maintenance hemodialysis patients: a three year follow-up. World J Gastroenterol 2007, 13:6037-6040.
20. Thanachartwet V., Phumratanaprapin W., Desakorn V., et al. Viral hepatitis infections among dialysis patients: Thailand registry report. Nephrology (Carlton) 2007, 12:399-405.
21. Moreira R.C., Deguti M.M., Lemos M.F., et al. HBV markers in haemodialysis Brazilian patients: a prospective 12-month follow-up. Mem Inst Oswaldo Cruz 2010, 105:107-108.
22. Alberú J., Lisker-Melman M., González M., et al. Prevalence of hepatitis B and C in patients registered on the cadaver kidney transplant waiting list in Mexico. Transplant Proc 1996, 28:3298-3300.
23. Burdick R.A., Bragg-Gresham J.L., Woods J.D., et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2003, 63:2222-2229.
24. Thomas F., Patrice M. Chronic hepatitis virus infections in patients on renal replacement therapy. Nephrol Dial Transplant 2004, 19:1049-1053.
25. Johnson D.W., Dent H., Yao Q., et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant 2009, 24:1598-1603.
26. López L., López P., Arago A., et al. Risk factors for hepatitis B and C in multi-transfused patients in Uruguay. J Clin Virol 2005, 34(suppl 2):S69-S74.